Microsoft's Amini says AI could cut drug discovery costs by targeting lab experiments
MSFT•Microsoft's Ava Amini said virtual experiments could reduce drug discovery costs and timelines by directing lab resources toward promising research. Eric Topol said a diagnostic system nearly doubled physicians' accuracy at lower cost in a study.




